Apri 28 0.15 mg (Desogestrel TABLET) 0.15 MG

APRI 28 0.15 MG is a contraceptive tablet containing desogestrel, used for birth control. This oral medication is designed to prevent pregnancy by altering the cervical mucus and ovulation process.

Strength

0.15 MG

Pack Size

Manufacturer / TM Owner

TEVA CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APRI 28 0.15 MG is primarily used for contraception. Desogestrel, the active ingredient, works by thickening the cervical mucus to prevent sperm from reaching the egg and by inhibiting ovulation in some cycles. This medication is often chosen for its convenience and effectiveness in preventing pregnancy when taken as directed.

Side Effects

Common effects of APRI 28 0.15 MG may include changes in menstrual bleeding patterns, such as lighter or irregular periods. Some users may experience headaches, nausea, or breast tenderness. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

APRI 28 0.15 MG should be handled with care. It is important to follow the prescribed regimen to maintain effectiveness. Users should be aware of potential interactions with other medications and consult a healthcare provider before starting this contraceptive, especially if there are pre-existing medical conditions.

Avoid Interactions

APRI 28 0.15 MG may interact with certain medications, including those that induce liver enzymes like some anticonvulsants and antibiotics. Alcohol consumption should be moderated, as it can affect the body's response to the medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

APRI 28 0.15 MG is used for contraception, helping to prevent pregnancy by altering cervical mucus and inhibiting ovulation.

APRI 28 0.15 MG is taken orally, typically once daily at the same time each day for consistent effectiveness.

Common side effects may include changes in menstrual bleeding, headaches, nausea, and breast tenderness.

APRI 28 0.15 MG may interact with certain medications, so it is important to consult a healthcare provider before combining it with other treatments.

APRI 28 0.15 MG may not be suitable for individuals with certain medical conditions or those taking specific medications. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.